Cara Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cara Therapeutics Inc announces closing of initial public offering and full exercise of underwriters' over-allotment option
Cara Therapeutics Inc:Says the closing of its initial public offering of 5,750,000 shares of common stock at a public offering price of $11.00 per share.Says this includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional shares of common stock at the same price to cover over-allotments.Says the net proceeds to Cara from the initial public offering were about $55.9 million.Says Stifel and Piper Jaffray & Co. acted as joint book-running managers for the offering. Canaccord Genuity Inc., Needham & Company, LLC and Janney Montgomery Scott LLC acted as co-managers.
Latest Developments for Cara Therapeutics Inc
- Share this
- Digg this